Interestingly, the selective activation of intestinal FXR appears to have a protective role, restricting abnormal growth of Lgr5+ cells and potentially curtailing the progression of colorectal cancer (CRC) [34]. The gene discussed is LGR5; the disease is colorectal carcinoma.